CERAVE DEVELOPED WITH DERMATOLOGISTS ACNE CONTROL CLEANSER OIL ABSORBING TECHNOLOGY- salicylic acid gel 
L'Oreal USA Products Inc

----------

Drug Facts

Active ingredient

Salicylic acid 2%

Purpose

Acne treatment

Uses

Warnings

For external use only

When using this product

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive ingredients

water, cocamidopropyl hydroxysultaine, glycerin, sodium lauroyl sarcosinate, niacinamide, sodium methyl cocoyl taurate, PEG-150 pentaerythrityl tetrastearate, gluconolactone, sodium cocoyl isethionate, ceramide NP, ceramide AP, ceramide EOP, carbomer, calcium gluconate, triethyl citrate, sodium hydroxide, sodium benzoate, sodium chloride, sodium lauroyl lactylate, cholesterol, coconut acid, tetrasodium EDTA, caprylyl glycol, hydrolyzed hyaluronic acid, trisodium ethylenediamine disuccinate, hectorite, phytosphingosine, xanthan gum, acrylates copolymer, benzoic acid

image of front label

image of front label
image of front label

image of back labelimage of back label

image of back label
CERAVE DEVELOPED WITH DERMATOLOGISTS ACNE CONTROL CLEANSER OIL ABSORBING TECHNOLOGY 
salicylic acid gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49967-840
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Salicylic Acid (UNII: O414PZ4LPZ) (Salicylic Acid - UNII:O414PZ4LPZ) Salicylic Acid20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
SODIUM LAUROYL SARCOSINATE (UNII: 632GS99618)  
COCAMIDOPROPYL HYDROXYSULTAINE (UNII: 62V75NI93W)  
GLYCERIN (UNII: PDC6A3C0OX)  
NIACINAMIDE (UNII: 25X51I8RD4)  
GLUCONOLACTONE (UNII: WQ29KQ9POT)  
SODIUM COCOYL ISETHIONATE (UNII: 518XTE8493)  
SODIUM METHYL COCOYL TAURATE (UNII: JVL98CG53G)  
PEG-150 PENTAERYTHRITYL TETRASTEARATE (UNII: 8L4OOQ76AM)  
XANTHAN GUM (UNII: TTV12P4NEE)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
HECTORITE (UNII: 08X4KI73EZ)  
TRISODIUM ETHYLENEDIAMINE DISUCCINATE (UNII: YA22H34H9Q)  
SODIUM LAUROYL LACTYLATE (UNII: 7243K85WFO)  
CHOLESTEROL (UNII: 97C5T2UQ7J)  
COCONUT ACID (UNII: 40U37V505D)  
EDETATE SODIUM (UNII: MP1J8420LU)  
CALCIUM GLUCONATE (UNII: SQE6VB453K)  
CERAMIDE NP (UNII: 4370DF050B)  
TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
CERAMIDE AP (UNII: F1X8L2B00J)  
PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
HYALURONIC ACID (UNII: S270N0TRQY)  
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
BENZOIC ACID (UNII: 8SKN0B0MIM)  
CERAMIDE 1 (UNII: 5THT33P7X7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49967-840-01473 mL in 1 BOTTLE; Type 0: Not a Combination Product03/31/2023
2NDC:49967-840-02355 mL in 1 BOTTLE; Type 0: Not a Combination Product03/31/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00603/31/2023
Labeler - L'Oreal USA Products Inc (002136794)
Establishment
NameAddressID/FEIBusiness Operations
L'OREAL USA, INC.960317444manufacture(49967-840) , pack(49967-840)
Establishment
NameAddressID/FEIBusiness Operations
L'Oreal USA Products, Inc.624244349manufacture(49967-840) , pack(49967-840)

Revised: 12/2023
Document Id: 4b9a02e9-8357-4df6-83b2-d62857041ae4
Set id: 7b622b57-21be-4870-a2fe-11447a9e321a
Version: 3
Effective Time: 20231228
 
L'Oreal USA Products Inc